GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » 3-Year Revenue Growth Rate
中文

Shanghai Pharmaceuticals Holding Co (SHSE:601607) 3-Year Revenue Growth Rate : 1.50% (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co 3-Year Revenue Growth Rate?

Shanghai Pharmaceuticals Holding Co's Revenue per Share for the three months ended in Dec. 2023 was ¥16.89.

During the past 12 months, Shanghai Pharmaceuticals Holding Co's average Revenue per Share Growth Rate was 6.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 1.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Shanghai Pharmaceuticals Holding Co was 141.00% per year. The lowest was -15.40% per year. And the median was 13.60% per year.


Competitive Comparison of Shanghai Pharmaceuticals Holding Co's 3-Year Revenue Growth Rate

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co's 3-Year Revenue Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's 3-Year Revenue Growth Rate falls into.



Shanghai Pharmaceuticals Holding Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Shanghai Pharmaceuticals Holding Co  (SHSE:601607) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Shanghai Pharmaceuticals Holding Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pharmaceuticals Holding Co (SHSE:601607) Business Description

Traded in Other Exchanges
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Headlines

No Headlines